Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chondrogen for Knee Osteoarthritis
NCT04520945Phase 2Unknown
- Sponsor
- Meluha Life Sciences
- Start
- Oct 2020
- Primary completion
- Sep 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Chondrogen in knee osteoarthritis (OA), sponsored by Meluha Life Sciences. Status: unknown.
02
Drugs
Chondrogen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04520945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04520945.